Ingenovis Health, recently announced that, as part of the company’s long-term succession planning process, Benjamin Mirtes, who has served as Ingenovis Health Chief Financial Officer since 2021, has been appointed Chief Executive Officer. He succeeds Bart Valdez, who led Ingenovis Health during a period of significant growth and change, and who will be transitioning away from Ingenovis Health by the end of the year. Michael Flaim, who joined the company in October 2024, will assume the role of Chief Financial Officer.
Under Valdez’s leadership, the company grew through an aggressive acquisition strategy, embraced an enterprise-wide technology integration, and launched the one-of-a-kind ACT program dedicated to the well-being and career advancement of clinicians.
Since joining the company in 2021, Mirtes has played a crucial role in establishing Ingenovis Health as a leader in the market, enabling the company to surpass USD 1.5 billion in annual revenue in 2023 through a targeted M&A, diversification and corporate strategy. He was an integral part of the company’s acquisition of four healthcare talent brands, while driving operational efficiencies, data and analytics and integration efforts. Mirtes’ efforts have been recognized both internally and externally – in 2023, he was named CFO of the Year by the Cincinnati Business Courier.
Stephen Trevor, Partner at Cornell Capital, noted, “During his time as CFO, Ben has been integral in building Ingenovis into a leading healthcare talent company, playing a critical role in bringing together eight likeminded workforce solutions brands – each a leader in their respective fields. With Ben’s financial and strategic expertise leveraging advanced data and technology, we are confident he is the right leader to drive the company’s continued growth and success as CEO. We thank Bart for his many years of dedication to building the Ingenovis platform and wish him the best in his next chapter.”
“Since joining Ingenovis Health three years ago, I’ve worked closely with Bart and our sponsors in evaluating and acquiring businesses that round out the Ingenovis portfolio. I’m proud of the outstanding talent we’ve brought together, and our future focus will be to drive growth from the diversified platform we have established,” said Mirtes. “I am grateful to the Board for this tremendous opportunity. At Ingenovis, we are proud of being a purpose-driven company, and I am honored to lead the dedicated and committed employees who fulfil our mission to be the home for healthcare talent.”
“Ben has the talent, drive and expertise to lead Ingenovis Health through this next phase of growth,” said Jeremy Lynch, Partner at Trilantic North America. “As our nation continues to address the healthcare talent shortage, we are confident that Ben and Michael will strengthen our position as part of the solution and support health systems nationwide in delivering excellent care to their communities.”
